Join to View Full Profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-498-5710
Dr. Itakura is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemResidency, Internal Medicine, 1999 - 2002
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1999
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology- Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology
Stanford UniversityPhD, Biomedical Informatics
Certifications & Licensure
CA State Medical License 2001 - 2025
PA State Medical License 2000 - 2002
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
American Board of Preventive Medicine Clinical Informatics
Clinical Trials
- Permission to Collect Blood Over Time for Research Start of enrollment: 2008 Aug 01
- The GORE Viabahn Endoprosthesis for the Treatment of Venous Occlusions and Stenoses Start of enrollment: 2010 Dec 01
Publications & Presentations
PubMed
- Response to anti-angiogenic therapy is affected by AIMP protein family activity in glioblastoma and lower-grade gliomas.Humaira Noor, Yuanning Zheng, Haruka Itakura, Olivier Gevaert
Biorxiv. 2025-03-14 - 13 citationsAntimicrobial exposure is associated with decreased survival in triple-negative breast cancer.Julia D Ransohoff, Victor Ritter, Natasha Purington, Karen Andrade, Summer Han
Nature Communications. 2023-04-12 - 5 citationsTreatment and Monitoring Variability in US Metastatic Breast Cancer Care.Jennifer L. Caswell-Jin, Alison Callahan, Natasha Purington, Summer S. Han, Haruka Itakura
JCO Clinical Cancer Informatics. 2021-05-27
Press Mentions
Susan G. Komen® Invests $21.7 Million in Research Focused on Improving Outcomes for Breast Cancer PatientsJune 22nd, 2022
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
